TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
29 hedge funds and large institutions have $8.59M invested in Talis Biomedical Corporation Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$20K | |
| 2 | +$9K | |
| 3 | +$3K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$382 |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$231K | |
| 3 | -$62.8K | |
| 4 |
Renaissance Technologies
New York
|
-$51.6K |
| 5 |
Millennium Management
New York
|
-$49.3K |